|
|
|
|
| LEADER |
03101nam a22005175i 4500 |
| 001 |
978-3-319-64113-3 |
| 003 |
DE-He213 |
| 005 |
20171027102644.0 |
| 007 |
cr nn 008mamaa |
| 008 |
171027s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319641133
|9 978-3-319-64113-3
|
| 024 |
7 |
|
|a 10.1007/978-3-319-64113-3
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a QK600-638
|
| 072 |
|
7 |
|a PSQ
|2 bicssc
|
| 072 |
|
7 |
|a PSAK
|2 bicssc
|
| 072 |
|
7 |
|a SCI086000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI029000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 579.135
|2 23
|
| 245 |
1 |
0 |
|a Current Progress in Medical Mycology
|h [electronic resource] /
|c edited by Héctor M. Mora-Montes, Leila M. Lopes-Bezerra.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a XII, 425 p. 59 illus., 49 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Chapter 1: Introduction to Medical Mycology -- Chapter 2: Antifungal Drugs -- Chapter 3: Candida and Candidiasis -- Chapter 4: Aspergillus and Aspergillosis -- Chapter 5: Histoplasma and Histoplasmosis -- Chapter 6: Cryptococcus and Cryptococcosis -- Chapter 7: Pneumocystis and Pneumocystosis -- Chapter 8: Coccidioides and Coccidioidomycosis -- Chapter 9: Paracoccidioides and Paraccocidioidomycosis -- Chapter 10: Sporothrix and Sporotrichosis -- Chapter 11: Fonsecaea and Chromoblastomycosis -- Chapter 12: Micetoma -- Chapter 13: Dermatophytes.
|
| 520 |
|
|
|a Infections caused by fungi have recently attracted the attention of both clinicians and basic researchers given the heavy burden they represent for any health system. The mortality and morbidity rates associated to mycosis are progressively rising simply because some of these diseases are still neglected by health-care workers and due to the changing sensitivity to antifungal drugs displayed by these organisms. In this book, both researchers and clinicians working in the medical mycology field explore the most recent literature about specific mycosis; placing in one concise chapter thoroughly revisions of the current knowledge on virulence factors, recognition by immune cells, immunoevasion, epidemiology, new diagnosis trends and therapeutics. This book is recommended to researchers, physicians and students interested in medical mycology.
|
| 650 |
|
0 |
|a Life sciences.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Medical microbiology.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
0 |
|a Mycology.
|
| 650 |
1 |
4 |
|a Life Sciences.
|
| 650 |
2 |
4 |
|a Mycology.
|
| 650 |
2 |
4 |
|a Medical Microbiology.
|
| 650 |
2 |
4 |
|a Microbiology.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 700 |
1 |
|
|a Mora-Montes, Héctor M.
|e editor.
|
| 700 |
1 |
|
|a Lopes-Bezerra, Leila M.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319641126
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-64113-3
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
